TERBINAFINE HCL 250 MG TABLET
For 30 tablets
Pharmacies pay
$4.28 filed
30 × $0.1426 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$8.38 filed
30 × $0.27931 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.0× estimated
Medicare paid 2.0× what pharmacies pay.
Part D averages every strength and form sold under “Terbinafine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$9.92 estimated
$4.28 + $0.64 (15%) + $5.00 fee per fill = $9.92
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
TERBINAFINE HCL 250 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “terbinafine”, “terbinafine hydrochloride” and “terbinafine tablets 250 mg”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them NorthStar Rx LLC, Breckenridge Pharmaceutical, Inc. and American Health Packaging.
FDA’s Established Pharmacologic Class for it is Allylamine Antifungal.
The NADAC file of 2026-10-14 prices it under 14 NDCs (National Drug Codes); the FDA directory lists 13 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $4.28 for 30 tablets (30 × $0.1426 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Amici Pharma, Inc. | 2 | $0.1426 per EA filed |
| Bionpharma Inc. | 2 | $0.1426 per EA filed |
| Chartwell RX, LLC | 2 | $0.1426 per EA filed |
| Cipla USA Inc. | 2 | $0.1426 per EA filed |
| NorthStar Rx LLC | 2 | $0.1426 per EA filed |
| American Health Packaging | 1 | $0.1426 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.1426 per EA filed |
| Breckenridge Pharmaceutical, Inc. | 1 | $0.1426 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.1426 per EA filed |
All 14 NDCs, with labeler and price
- 16714-0795-01 · NorthStar Rx LLC · $0.1426 per EA · eff. 2026-09-23 filed
- 16714-0795-02 · NorthStar Rx LLC · $0.1426 per EA · eff. 2026-09-23 filed
- 51991-0526-01 · Breckenridge Pharmaceutical, Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 60687-0909-11 · not listed as a package in the FDA directory · $0.1426 per EA · eff. 2026-09-23 filed
- 60687-0909-21 · American Health Packaging · $0.1426 per EA · eff. 2026-09-23 filed
- 62135-0572-30 · Chartwell RX, LLC · $0.1426 per EA · eff. 2026-09-23 filed
- 62135-0572-90 · Chartwell RX, LLC · $0.1426 per EA · eff. 2026-09-23 filed
- 65862-0079-30 · Aurobindo Pharma Limited · $0.1426 per EA · eff. 2026-09-23 filed
- 69097-0859-02 · Cipla USA Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 69097-0859-07 · Cipla USA Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 69292-0225-01 · Amici Pharma, Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 69292-0225-30 · Amici Pharma, Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 69452-0351-13 · Bionpharma Inc. · $0.1426 per EA · eff. 2026-09-23 filed
- 69452-0351-20 · Bionpharma Inc. · $0.1426 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share an FDA nonproprietary name with TERBINAFINE HCL 250 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ATHLETE'S FOOT 1% CREAM | $0.06293 to $0.39833 per GM filed | We don’t know yet |
| FT ATHLETE'S FOOT 1% CREAM | $0.11771 to $0.30853 per GM filed | We don’t know yet |
| TERBINAFINE 1% CREAM | $0.23063 to $0.39833 per GM filed | We don’t know yet |
| TERBINAFINE HCL 250 MG TABLET this page | $0.1426 per EA filed | $0.27931 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
Medicare Part D paid $8.38 for 30 tablets, at an average of $0.27931 per EA in 2024 (2024-01-01 to 2024-12-31) for “Terbinafine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 799,100 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for TERBINAFINE HCL 250 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Terbinafine HCl / Terbinafine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.